Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebo-controlled trial

PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis

(2012) P. W. Weijenborg et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study

(2011) B. Braak et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease

(2010) B. NOJKOV et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease

(2009) R. FASS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Overutilization of Proton Pump Inhibitors: A Review of Cost-Effectiveness and Risk in PPI

(2009) Joel J Heidelbaugh et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease

(2009) E Savarino et al.   GUT

Management of heartburn not responding to proton pump inhibitors

(2009) R Fass et al.   GUT

Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) L VANKERKHOVEN et al.   Clinical Gastroenterology and Hepatology

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

(2008) A C Ford et al.   GUT